Journal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

The Brazilian Journal of Infectious Diseases, published by Elsevier Brazil, is a premier open-access journal dedicated to advancing research and clinical practice in the field of infectious diseases. Since its inception in 2001, this journal has been pivotal in disseminating innovative studies and reviews that inform healthcare professionals and researchers alike. With an impressive impact factor reflected by its ranking in the second quartile for Infectious Diseases and third quartile for Medical Microbiology in 2023, the journal ranks #127 out of 344 in medicine – infectious diseases and #61 out of 140 in medical microbiology, showcasing its reputable standing in the scientific community. The Brazilian Journal of Infectious Diseases invites contributions that highlight significant findings, novel methodologies, and critical reviews aimed at enhancing patient care and public health initiatives. With an international readership and a focus on pressing issues in infectious diseases, it serves as an essential platform for knowledge exchange and collaboration among scholars and practitioners across Brazil and beyond. By reinforcing the importance of open access to scientific literature, this journal not only promotes transparency but also enhances the global discourse surrounding infectious diseases.

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

INFECTION is a prestigious journal, published by Springer Heidelberg, that serves as a leading platform for the dissemination of critical research in the fields of Infectious Diseases, Microbiology, and Medicine. With an impressive Q1 ranking in multiple categories such as Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, the journal is recognized for its high-quality content and impactful contributions to the scientific community, as evidenced by its Scopus rankings placing it in the top 10th percentiles. Since its inception in 1973, and projected to continue until 2024, INFECTION has established itself as a vital resource for researchers, healthcare professionals, and students keen to explore the latest findings and advancements in infectious diseases. The journal provides a rigorous peer-review process, ensuring that only high-quality studies are published, making it an essential read for those seeking to deepen their understanding and stay abreast of the rapidly evolving landscape in infection research.

EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE is a prominent scholarly journal published by CESKA LEKARSKA SPOLECNOST J EV PURKYNE in the Czech Republic. With an ISSN of 1210-7913, this journal has been at the forefront of research since its inception in 1994, showcasing a rich repository of studies bridging the domains of epidemiology, microbiology, immunology, and infectious diseases, and reflecting advancements over three decades. Although it currently falls within the Q4 category in multiple fields including Epidemiology and Microbiology, the journal serves an essential role in disseminating knowledge and fostering discussions around public health challenges. The contributions made through its pages are vital for researchers, healthcare professionals, and students aiming to enhance their understanding of complex biomedical issues. While it does not offer open access, the journal remains a critical resource in its niches, inviting readers to engage with the latest findings and methodologies reshaping the landscape of health science.

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

The BRAZILIAN JOURNAL OF MICROBIOLOGY, published by SPRINGER, stands as a pivotal platform in the field of microbiology, offering an open access model since 2000. With the ISSN 1517-8382 and E-ISSN 1678-4405, this esteemed journal encourages the dissemination of groundbreaking research and innovative methodologies that contribute to the understanding of microbial life, its role in health and disease, and its environmental impact. Based in Switzerland and accessible globally, the journal’s categorization in the Q3 quartile for Microbiology reflects its commitment to quality and relevance in the scientific community. As of 2023, it ranks 121 out of 182 in the Scopus listings for Microbiology, further highlighting its growing influence in immunology and microbiological research. With converged years spanning from 1992 to 2024, the journal continues to support a diverse range of studies, making it an invaluable resource for researchers, professionals, and students alike.

Indian Journal of Pathology and Microbiology, published by Wolters Kluwer Medknow Publications, is a distinguished open-access journal that has been fostering knowledge dissemination in the fields of pathology and microbiology since 2008. With an ISSN of 0377-4929 and E-ISSN 0974-5130, this journal serves as a critical resource for researchers and practitioners committed to advancing their understanding of medical sciences in India and beyond. Spanning decades of valuable research contributions since its establishment in 1972, it provides a platform for peer-reviewed articles that explore current trends and innovations in medicinal pathology and microbiological studies. Although it holds a Q4 ranking in categories such as medicine and microbiology, it maintains a notable Q3 classification in pathology and forensic medicine, highlighting its relevance to contemporary scientific discussions. Accessible freely to a global audience, the journal plays a pivotal role in enhancing scholarly communication and collaboration, making it an indispensable tool for students, professionals, and researchers alike aiming to contribute to this evolving discipline.